UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2014

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F

Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes

ISRAEL CHEMICALS LTD.

1.	Immediate Report dated November 12, 2014 regarding a Dividend Distribution.

Item 1

November 11, 2014

Immediate Report Regarding a Dividend Distribution

The Company wishes to report that its Board of Directors, in its meeting of November 11, 2014, has decided to distribute a dividend in cash out of the revenues of the third quarter, 2014 in the amount of $125,000,000. The dividend amount per share is US$ 0.09832.

Some shareholders will receive the payment in NIS and need to take into account the following: the amount of the dividend per share is not final and will be subject to changes due to the need to convert the amount from US Dollars to Israeli Shekels (NIS), according to the Bank of Israel representative exchange rate known on December 2, 2014.

The dividend will be paid only to registered shareholders entitled to US$2 or above.

The record date is December 3, 2014; the payment day is December 17, 2014. In the current quarter, a tax of 15% will be deducted. The tax rate for foreign residents is 15% or according to International Tax Treaties, at the lower.

Sincerely,

ICL Chemicals

Name of the authorized signatory on the report and name of authorized electronic reporter: Lisa Haimovitz.

Position: VP General Counsel and Company Secretary.

Signature Date: November 11, 2014

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 12, 2014

Israel Chemicals Ltd.

/s/ Avi Doitchman

Avi Doitchman

Executive Vice President, Chief Financial Officer & Strategy